Andy N. Mead

Pfizer Ltd, UK, Sandwich, England, United Kingdom 
Drug addiction
"Andy Mead"
Mean distance: 16.24 (cluster 6)


Sign in to add mentor
Dai Stephens grad student 1995-1999 University of Sussex
 (Andy spent a couple of stints in the lab, the first as grad student, the second as post doc)


Sign in to add trainee
Eoin C. OConnor grad student 2007-2011 Pfizer
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wager TT, Chandrasekaran RY, Bradley J, et al. (2014) Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior. Acs Chemical Neuroscience. 5: 1253-65
Mead AN. (2014) Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery. Expert Opinion On Drug Discovery. 9: 1281-91
Horton DB, Potter DM, Mead AN. (2013) A translational pharmacology approach to understanding the predictive value of abuse potential assessments. Behavioural Pharmacology. 24: 410-36
O'Connor EC, Chapman K, Butler P, et al. (2011) The predictive validity of the rat self-administration model for abuse liability. Neuroscience and Biobehavioral Reviews. 35: 912-38
O'Connor EC, Mead AN. (2010) Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans. Pharmacology, Biochemistry, and Behavior. 96: 279-86
O'Connor EC, Crombag HS, Mead AN, et al. (2010) The mGluR5 antagonist MTEP dissociates the acquisition of predictive and incentive motivational properties of reward-paired stimuli in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1807-17
O'Connor EC, Parker D, Rollema H, et al. (2010) The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology. 208: 365-76
Bilsland JG, Wheeldon A, Mead A, et al. (2008) Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 685-700
Mead AN, Zamanillo D, Becker N, et al. (2007) AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 343-53
Mead AN, Morris HV, Dixon CI, et al. (2006) AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice. Behavioral Neuroscience. 120: 241-8
See more...